[
  {
    "ts": null,
    "headline": "Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More",
    "summary": "NVIDIA, Insulet and Howmet Aerospace have been selected as the top picks with a high net income ratio.",
    "url": "https://finnhub.io/api/news?id=9067add8dcfe0e9bfeddedfdb1944fb2d849cd810b8b2a89598fdeae90c77841",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731441900,
      "headline": "Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More",
      "id": 131329798,
      "image": "https://media.zenfs.com/en/zacks.com/f8e8dd74fec7b16eb85235be391efa80",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "NVIDIA, Insulet and Howmet Aerospace have been selected as the top picks with a high net income ratio.",
      "url": "https://finnhub.io/api/news?id=9067add8dcfe0e9bfeddedfdb1944fb2d849cd810b8b2a89598fdeae90c77841"
    }
  },
  {
    "ts": null,
    "headline": "Why Insulet (PODD) is a Top Growth Stock for the Long-Term",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=8edd3f5d23f45a51ac386c78b9ab6bba82908ad4068c12e85d11c7b1a4ed6733",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731422712,
      "headline": "Why Insulet (PODD) is a Top Growth Stock for the Long-Term",
      "id": 131306693,
      "image": "https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=8edd3f5d23f45a51ac386c78b9ab6bba82908ad4068c12e85d11c7b1a4ed6733"
    }
  },
  {
    "ts": null,
    "headline": "Baird Q3 2024 Small/Mid Cap Growth Equity Fund Commentary",
    "summary": "Baird Small/Mid Cap Growth portfolio increased +6.9% in 3Q, net of fees, compared to the +7.0% increase in our primary benchmark, the Russell 2500 Growth Index.",
    "url": "https://finnhub.io/api/news?id=b68746b284399031eb494c65af6b9738b70a5933971ec05b3029b7781e2a7597",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731418080,
      "headline": "Baird Q3 2024 Small/Mid Cap Growth Equity Fund Commentary",
      "id": 131308611,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/551986071/image_551986071.jpg?io=getty-c-w1536",
      "related": "PODD",
      "source": "SeekingAlpha",
      "summary": "Baird Small/Mid Cap Growth portfolio increased +6.9% in 3Q, net of fees, compared to the +7.0% increase in our primary benchmark, the Russell 2500 Growth Index.",
      "url": "https://finnhub.io/api/news?id=b68746b284399031eb494c65af6b9738b70a5933971ec05b3029b7781e2a7597"
    }
  },
  {
    "ts": null,
    "headline": "PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up",
    "summary": "Insulet's third-quarter performance benefits from the continued high demand for Omnipod 5.",
    "url": "https://finnhub.io/api/news?id=59151d5d1d4904c35e38bbb967eca3a9ebf1832f76ea87fb48c8116c2c82a2cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731417000,
      "headline": "PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up",
      "id": 131306696,
      "image": "https://media.zenfs.com/en/zacks.com/0ebf144352a95b22dfed01b36b0e82c5",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Insulet's third-quarter performance benefits from the continued high demand for Omnipod 5.",
      "url": "https://finnhub.io/api/news?id=59151d5d1d4904c35e38bbb967eca3a9ebf1832f76ea87fb48c8116c2c82a2cf"
    }
  },
  {
    "ts": null,
    "headline": "Baird Q3 2024 Mid Cap Growth Equity Fund Commentary",
    "summary": "For the quarter, the Baird Mid Cap Growth portfolio produced a positive return of +5.2%, net of fees, trailing the Russell Midcap Growth increase of +6.5%.",
    "url": "https://finnhub.io/api/news?id=a5b25b172fd69ded4c1f4c5ea64982a4f9378df0e24158bd4b779aacbff79a2a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731414240,
      "headline": "Baird Q3 2024 Mid Cap Growth Equity Fund Commentary",
      "id": 131307419,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2157585497/image_2157585497.jpg?io=getty-c-w1536",
      "related": "PODD",
      "source": "SeekingAlpha",
      "summary": "For the quarter, the Baird Mid Cap Growth portfolio produced a positive return of +5.2%, net of fees, trailing the Russell Midcap Growth increase of +6.5%.",
      "url": "https://finnhub.io/api/news?id=a5b25b172fd69ded4c1f4c5ea64982a4f9378df0e24158bd4b779aacbff79a2a"
    }
  },
  {
    "ts": null,
    "headline": "Insulet price target raised to $317 from $234 at Morgan Stanley",
    "summary": "Morgan Stanley raised the firm’s price target on Insulet (PODD) to $317 from $234 and keeps an Overweight rating on the shares. Insulet “had a strong 3Q print,” says the analyst, who cites “high quality growth, strong cash flow characteristics, and catalysts on the horizon” for the firm’s higher target following the company’s quarterly report. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Re",
    "url": "https://finnhub.io/api/news?id=e03d3c27e2ba5d4817a3484a81f472ca841fdca2ff090c4b57dac394092afb2a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731411921,
      "headline": "Insulet price target raised to $317 from $234 at Morgan Stanley",
      "id": 131306699,
      "image": "https://media.zenfs.com/en/tipranks_452/1e5c62569304a546b8f4bd9cc2d706a2",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Morgan Stanley raised the firm’s price target on Insulet (PODD) to $317 from $234 and keeps an Overweight rating on the shares. Insulet “had a strong 3Q print,” says the analyst, who cites “high quality growth, strong cash flow characteristics, and catalysts on the horizon” for the firm’s higher target following the company’s quarterly report. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Re",
      "url": "https://finnhub.io/api/news?id=e03d3c27e2ba5d4817a3484a81f472ca841fdca2ff090c4b57dac394092afb2a"
    }
  }
]